Abstract:Mycoplasma pneumoniae is an important pathogen causing upper and lower respiratory tract infections in children and other age groups. Macrolides are the recommended treatments of choice for M. pneumoniae infections. However, macrolide resistance in M. pneumoniae is increasing worldwide, which complicates the treatment strategies. The mechanisms of macrolide resistance have been extensively studied focusing on the mutations in 23S rRNA and ribosomal proteins. Since the secondary treatment choice for pediatric patients is very limited, we decided to look for potential new treatment strategies in macrolide drugs and investigate possible new mechanisms of resistance. We performed an in vitro selection of mutants resistant to five macrolides (erythromycin, roxithromycin, azithromycin, josamycin, and midecamycin) by inducing the parent M. pneumoniae strain M129 with increasing concentrations of the drugs. The evolving cultures in every passage were tested for their antimicrobial susceptibilities to eight drugs and mutations known to be associated with macrolide resistance by PCR and sequencing. The final selected mutants were also analyzed by whole-genome sequencing. Results showed that roxithromycin is the drug that most easily induces resistance (at 0.25 mg/L, with two passages, 23 days), while with midecamycin it is most difficult (at 5.12 mg/L, with seven passages, 87 days). Point mutations C2617A/T, A2063G, or A2064C in domain V of 23S rRNA were detected in mutants resistant to the 14- and 15-membered macrolides, while A2067G/C was selected for the 16-membered macrolides. Single amino acid changes (G72R, G72V) in ribosomal protein L4 emerged during the induction by midecamycin. Genome sequencing identified sequence variations in dnaK, rpoC, glpK, MPN449, and in one of the hsdS (MPN365) genes in the mutants. Mutants induced by the 14- or 15-membered macrolides were resistant to all macrolides, while those induced by the 16-membered macrolides (midecamycin and josamycin) remained susceptible to the 14- and 15-membered macrolides. In summary, these data demonstrated that midecamycin is less potent in inducing resistance than other macrolides, and the induced resistance is restrained to the 16-membered macrolides, suggesting a potential benefit of using midecamycin as a first treatment choice if the strain is susceptible.

Research Progress on the Macrolide Efflux Gene

Mobile Macrolide Resistance Genes in Staphylococci.

Genes related to chloramphenicol,tetracycline,rifampicin and trimethoprim-sulfamethoxazole resistance in multi-drug resistant Acinetobacter baumannii

Ultrastructural, metabolic and genetic characteristics of determinants facilitating the acquisition of macrolide resistance by Streptococcus pneumoniae

Molecular Characterization of Erm(b)- and Mef(e)-Mediated Erythromycin-Resistant Streptococcus Pneumoniae in China and Complete DNA Sequence of Tn2010

[Characterization of Macrolide-Resistance Mediated by Transposable Elements Tn1545 and Tn917 in Clinical Isolates of Streptococcus Pneumoniae].

Identification of Novel Mobile Colistin Resistance Gene Mcr-10

Inducible Expression Of Both Ermb And Ermt Conferred High Macrolide Resistance In Streptococcus Gallolyticus Subsp Pasteurianus Isolates In China

Whole Genome Analysis Reveals New Insights into Macrolide Resistance in Mycoplasma pneumoniae

Mutational and Transcriptomic Changes Involved in the Development of Macrolide Resistance in Campylobacter Jejuni

Use of Next Generation Sequence to Investigate Potential Novel Macrolide Resistance Mechanisms in A Population of Moraxella Catarrhalis Isolates

Distribution of Serotypes, Genotypes, and Resistance Determinants among Macrolide-Resistant Streptococcus Pneumoniae Isolates.

Molecular epidemiology and analysis on resistant mechanisms of macrolide-nonsusceptible Moraxella catarrhals

Macrolide Resistance and Pulsed-Field Gel Electrophoresis Typing of 46 Streptococcus Suis Isolates

Macrolides mediate transcriptional activation of the msr(E)-mph(E) operon through histone-like nucleoid-structuring protein (HNS) and cAMP receptor protein (CRP)

The intrinsic macrolide resistome of Escherichia coli

Novel mechanisms of macrolide resistance revealed by <i>in vitro</i> selection and genome analysis in <i>Mycoplasma pneumoniae</i>

MAB_2355c Confers Macrolide Resistance in Mycobacterium abscessus by Ribosome Protection

Gene expression profile of Campylobacter jejuni in response to macrolide antibiotics

Quantitative proteomics analysis of Mycoplasma pneumoniae identifies potential macrolide resistance determinants

Induction of Macrolide Resistance in Mycoplasma Gallisepticum in Vitro and Its Resistance-Related Mutations Within Domain V of 23S Rrna.